E-DRUG: Therapeutics Letter #63 on mild hypertension
----------------------------------------------
THERAPEUTICS LETTER #63 (Mar-Apr 2007): Mild Hypertension - Using
Framingham: http://ti.ubc.ca/en/node/152
I would like to bring to your attention the latest issue (#63) of the
Therapeutics Letter: "Using Framingham for primary prevention cardiovascular
risk assessment" that has just been posted on the Therapeutics Initiative
web site at http://ti.ubc.ca/en/node/152
This Letter is a continuation of the previous Letter and presents an
alternative method (Framingham calculators) of estimating cardiovascular
risk in a common presentation in family practice.
I invite you to drop by and have a look at this Letter. Please feel free to
forward this message to any of your friends or colleagues that might be
interested in this topic.
We would appreciate receiving your comments on this Therapeutics Letter and
its possible implications in clinical practice.
Regards,
Ciprian Jauca
Program Coordinator
Therapeutics Initiative
University of British Columbia
Department of Anesthesiology, Pharmacology & Therapeutics
2176 Health Sciences Mall
Vancouver, BC V6T 1Z3
Canada
Email: jauca@ti.ubc.ca
Tel: +1-604-822-0700
Fax: +1-604-822-0701
Web: www.ti.ubc.ca